Bloodworks is focused on innovative ways to improve patient care. Current research projects are tackling some of the most critical problems in medicine today, and will potentially save hundreds of thousands of lives. Our goals:
- Better therapies and cures for bleeding disorders like hemophilia — by researching biochemical structures and genetics of plasma proteins.
- A screening process for transplant patients that will more accurately match them with donors, save precious time, and lead to more successful organ transplants.
- Establishing an advanced genomics laboratory that will improve blood and tissue typing, further enhancing the success of transfusions and transplants.
- Improving platelet therapies for cancer patients and soldiers on the battlefield.
- Pioneering advances in the processing and storage of umbilical cord blood, which is used to treat people with life-threatening illnesses such as leukemia and aplastic anemia.
- Correcting blood disorders with the use of gene transfer therapy.
Our research expertise is recognized through prestigious grants from the leading national organizations, including:
- National Institutes of Health
- National Heart, Lung and Blood Institute
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Disease
- National Institute of General Medical Sciences
- Department of Health and Human Services
- Maternal and Child Health Bureau
- Centers for Disease Control
- Department of Defense
- American Heart Association
- Biogen Idec, Inc.
- Novo Nordisk, Inc.
- Bayer Pharmaceuticals, Inc.
- J. Murdock Charitable Trust
- The Seattle Foundation
We are committed to advancing transfusion medicine, enhancing patient care, and discovering tomorrow’s cures.
Our blood research saves lives.